| abstract |
Vaccine / inhibitor combination, comprising: i) as a vaccine, an RNA vaccine comprising at least one RNA, wherein said at least one RNA is an mRNA, comprising at least one open reading frame (ORF) encoding for at least one antigen and ii) as an inhibitor, a composition comprising a PD-1 pathway inhibitor, where the PD-1 pathway inhibitor is an antagonistic antibody directed against PD-L1. |